# Grünenthal acquires full ownership of Grünenthal Meds from Kyowa Kirin

Grünenthal acquired Kyowa Kirin International's 49% stake in Grünenthal Meds, taking full ownership of the joint venture and its portfolio of 12 established medicine brands with €170 million in revenue.

- Type: Acquisition
- Announced: 2026-03-02
- Where: Germany
- Status: announced
- Products: pain management medicines (Abstral, PecFent), opioid-induced constipation treatment (Moventig), osteoporosis supplement (Adcal-D3)
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Grünenthal](https://endata.com/companies/21459.md) (acquirer)
- [Kyowa Kirin International](https://endata.com/companies/90613.md) (target)
- [Grünenthal Meds](https://endata.com/companies/90614.md) (target)

## Sources

- [americanpharmaceuticalreview.com](https://www.americanpharmaceuticalreview.com/1315-News/624382-Gr-nenthal-Takes-Full-Ownership-of-Gr-nenthal-Meds-the-JV-Established-with-Kyowa-Kirin-for-its-Medicine-Brands/), 2026-03-02: "The integration of 'Grünenthal Meds' confirms our leading capabilities in deal execution and integration and successfully concludes one of the most complex undertakings of our M&A journey."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.